Anti-Neutrophil Cytoplasmic Antibody By IFA

Includes C-ANCA and P- ANCA

Preferred Specimen(s) 1 mL serum

Transport Container Plastic screw-cap vial

Transport Temperature

  • Room temperature: Not defined,
  • Refrigerated 7 days,
  • -20oC Long term

Reject Criteria

  • Gross hemolysis;
  • Gross lipemic

Methodology Immunofluorescent Assay (IFA)

Clinical Significance Testing for anti-neutrophil cytoplasmic antibodies (PANCA and/or ANCA-IBD) has been found to be useful in establishing the diagnosis of suspected vascular diseases (e.g., crescentric glomerulonephritis, microscopic polyarteritis and Churg-Strauss syndrome), bowel disease (e.g., Crohn’s Disease, ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis) as well as with other autoimmune diseases (e.g., drug-induced lupus, SLE, and Felty’s syndrome).